RADX
Radiopharm Theranostics Limited
Set alert
1.08 USD -0.04 -3.26%
1.08 Day range 1.16
0.90 52-week range 10.63
- YTD
- -79.31%
- 1 year
- -79.11%
- Open
- 1.09
- Prev close
- 1.12
- Mkt cap
- 16.96M
- Vol
- 8.92K
- Avg vol
- 56.66K
- EPS
- -3.64
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.08
- High
- 1.16
- Forward P/E
- 0.00
- Beta
- 0.85
- Short ratio
- 0.00
- Inst. own
- 0.00%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 7.67
- 200-d avg
- 7.67
- 1y target
- 0.00
1Y chart
Closing price and volume
Compare RADX
Chart and line up RADX against other symbols or a saved comparison set.
- RADX Radiopharm Theranostics Limited
1.08
-0.04 -3.26%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | RADX | SPY | QQQ |
|---|---|---|---|
| Last price | 1.08 | 755.72 | 690.49 |
| Change | -0.0364 | -13.64 | -24.85 |
| Change % | -3.26% | -1.77% | -3.47% |
| Open | 1.09 | 761.38 | 697.13 |
| Day high | 1.16 | 761.46 | 698.63 |
| Day low | 1.08 | 750.36 | 683.45 |
| Previous close | 1.12 | 769.36 | 715.34 |
| Volume | 8.92K | 77.70M | 85.24M |
| Average volume | 56.66K | 41.22M | 34.57M |
| Market cap | 16.96M | 812.08B | 483.28B |
| P/E ratio | 0.00 | 23.99 | 26.44 |
| Earnings per share | -3.64 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 10.63 | 779.09 | 759.66 |
| 52-week low | 0.90 | 631.97 | 558.28 |
| 1-week return | +6.93% | -0.559233% | -1.97% |
| 1-month return | -33.33% | -0.906075% | -6.66% |
| 3-month return | -66.25% | +1.89% | +1.02% |
| 6-month return | -74.71% | +5.16% | +3.41% |
| Year-to-date return | -79.31% | +10.82% | +12.40% |
| 1-year return | -79.11% | +11.16% | +10.29% |
| 2-year return | -93.89% | +32.90% | +42.71% |
| 50-day moving average | 1.61 | 767.63 | 725.41 |
| 200-day moving average | 3.70 | 728.53 | 679.17 |
| Target price | — | — | — |
| Beta | 0.851 | 0.00 | 0.00 |
| Short ratio | — | — | — |
| Institutional ownership | — | — | — |